Advances in Biomarkers

In biomedical contexts, a biomarker, or biological marker, is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated using blood, urine, or soft tissues to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientific fields.

In the present book, ten typical literatures about biomarker published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on biomarker. We hope this book can demonstrate advances in biomarker as well as give references to the researchers, students and other related people.

Sample Chapter(s)
Preface (94 KB)
Components of the Book:
  • Chapter 1
    The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update
  • Chapter 2
    Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study
  • Chapter 3
    Diagnostic biomarker kinetics: how brain‑derived biomarkers distribute through the human body, and how this affects their diagnostic significance: the case of S100B
  • Chapter 4
    Estimated glucose disposal rate as a candidate biomarker for thrombotic biomarkers in T1D: a pooled analysis
  • Chapter 5
    Why did European Radiology reject my radiomic biomarker paper? How to correctly evaluate imaging biomarkers in a clinical setting
  • Chapter 6
    Plasma biomarkers TAP, CPA1, and CPA2 for the detection of pancreatic injury in rat: the development of a novel multiplex IA‑LC‑MS/MS assay and biomarker performance evaluation
  • Chapter 7
    Study design for development of novel safety biomarkers of drug‑induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study
  • Chapter 8
    Biomarker heatmaps: visualization of complex biomarker data to detect storm-induced source changes in fluvial particulate organic carbon
  • Chapter 9
    The Biomarker Toolkit — an evidence‑based guideline to predict cancer biomarker success and guide development
  • Chapter 10
    Functional principal component analysis and sparse‑group LASSO to identify associations between biomarker trajectories and mortality among hospitalized SARS‑CoV‑2 infected individuals
Readership: Students, academics, teachers and other people attending or interested in Biomarkers.
Marina Boccardi
German Center for Neurodegenerative Diseases DZNE-Standort Rostock/Greifswald, Gehlsheimer Str. 20, 18147 Rostock, Germany.

Reem D. Mahmood
Christie NHS Foundation Trust,Wilmslow Road,Withington, Manchester M20 4BX, UK.

Robert Murcko
FloTBI Inc., Cleveland, OH, USA.

L. L. O’Mahoney
Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK.

Steve Halligan
Centre forMedical Imaging, University College LondonUCL, 43-45 Foley Street, London W1W 7TS, UK.

Katerina Vlasakova
Merck & Co., Inc., 770 Sumneytown Pike, WP-45-320,West Point, PA 19486, USA.

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top